Yuji Eso

1.3k total citations
52 papers, 806 citations indexed

About

Yuji Eso is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Yuji Eso has authored 52 papers receiving a total of 806 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Hepatology, 16 papers in Surgery and 15 papers in Epidemiology. Recurrent topics in Yuji Eso's work include Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Liver Disease Diagnosis and Treatment (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Yuji Eso is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (20 papers), Liver Disease Diagnosis and Treatment (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (9 papers). Yuji Eso collaborates with scholars based in Japan and United States. Yuji Eso's co-authors include Hiroyuki Marusawa, Hiroshi Seno, Atsushi Takai, Haruhiko Takeda, Takahiro Shimizu, Ken Takahashi, Tsutomu Chiba, Kojiro Taura, Yoshihide Ueda and Shigeharu Nakano and has published in prestigious journals such as Gastroenterology, Cancer Research and Scientific Reports.

In The Last Decade

Yuji Eso

50 papers receiving 795 citations

Peers

Yuji Eso

HEPAT

ONCOL

EPIDE

Weiqi Rong China

Jie Mei China

Yabing Cao China

Anna Kan China

Akhil Chopra Singapore

Feng Wen China

Antonio Cubillo Gracián Spain

Kornelius Schulze Germany

Adarsh Joshi United States

Weiqi Rong China

Yuji Eso

490 ×1.3

HEPAT

234 ×0.8

ONCOL

203 ×0.8

EPIDE

192 ×1.1

161 ×1.1

Citations per year, relative to Yuji Eso Yuji Eso (= 1×) peers Weiqi Rong

Countries citing papers authored by Yuji Eso

Since Specialization

Citations

This map shows the geographic impact of Yuji Eso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuji Eso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuji Eso more than expected).

Fields of papers citing papers by Yuji Eso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuji Eso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuji Eso. The network helps show where Yuji Eso may publish in the future.

Co-authorship network of co-authors of Yuji Eso

This figure shows the co-authorship network connecting the top 25 collaborators of Yuji Eso. A scholar is included among the top collaborators of Yuji Eso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuji Eso. Yuji Eso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Mishima, Masako, Atsushi Takai, Haruhiko Takeda, et al.. (2024). TERT upregulation promotes cell proliferation via degradation of p21 and increases carcinogenic potential. The Journal of Pathology. 264(3). 318–331. 6 indexed citations

Takeda, Haruhiko, Atsushi Takai, Eriko Iguchi, et al.. (2023). Evolutional transition of HBV genome during the persistent infection determined by single-molecule real-time sequencing. Hepatology Communications. 7(3). e0047–e0047. 2 indexed citations

Takeda, Haruhiko, Yoshihide Ueda, Atsushi Takai, et al.. (2022). Mutational spectrum of hepatitis C virus in patients with chronic hepatitis C determined by single molecule real-time sequencing. Scientific Reports. 12(1). 7083–7083. 5 indexed citations

Eso, Yuji, Shigeharu Nakano, Masako Mishima, et al.. (2021). A simplified method to quantitatively predict the effect of lenvatinib on hepatocellular carcinoma using contrast-enhanced ultrasound with perfluorobutane microbubbles. Quantitative Imaging in Medicine and Surgery. 11(6). 2766–2774. 3 indexed citations

Iguchi, Eriko, Atsushi Takai, Haruhiko Takeda, et al.. (2021). Author Correction: DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis. Scientific Reports. 11(1). 14037–14037. 1 indexed citations

Iguchi, Eriko, Atsushi Takai, Haruhiko Takeda, et al.. (2020). DNA methyltransferase 3B plays a protective role against hepatocarcinogenesis caused by chronic inflammation via maintaining mitochondrial homeostasis. Scientific Reports. 10(1). 21268–21268. 8 indexed citations

Nakano, Shigeharu, Yuji Eso, Hirokazu Okada, et al.. (2020). Recent Advances in Immunotherapy for Hepatocellular Carcinoma. Cancers. 12(4). 775–775. 59 indexed citations

Ogiso, Satoshi, Satoru Seo, Yuji Eso, et al.. (2020). Laparoscopic liver resection versus percutaneous radiofrequency ablation for small hepatocellular carcinoma. HPB. 23(4). 533–537. 18 indexed citations

Eso, Yuji. (2020). Microsatellite instability analysis using multiplex polymerase chain reaction with fluorescently labeled primers for amplification of five mononucleotide repeat markers. Hepatology Research. 50(12). 1391–1392. 1 indexed citations

10.

Eso, Yuji, Takahiro Shimizu, Haruhiko Takeda, Atsushi Takai, & Hiroyuki Marusawa. (2019). Microsatellite instability and immune checkpoint inhibitors: toward precision medicine against gastrointestinal and hepatobiliary cancers. Journal of Gastroenterology. 55(1). 15–26. 125 indexed citations

11.

Matsumoto, Tomonori, Atsushi Takai, Yuji Eso, et al.. (2017). Proliferating EpCAM-Positive Ductal Cells in the Inflamed Liver Give Rise to Hepatocellular Carcinoma. Cancer Research. 77(22). 6131–6143. 48 indexed citations

12.

Eso, Yuji, Norimitsu Uza, H Yamagishi, et al.. (2017). Utility of KRAS mutational analysis in the preoperative diagnosis of synchronous pancreatic cancer and intrahepatic cholangiocarcinoma. Medicine. 96(50). e9217–e9217. 2 indexed citations

13.

Eso, Yuji, Atsushi Takai, Tomonori Matsumoto, et al.. (2016). MSH2 Dysregulation Is Triggered by Proinflammatory Cytokine Stimulation and Is Associated with Liver Cancer Development. Cancer Research. 76(15). 4383–4393. 24 indexed citations

14.

Eso, Yuji, Atsushi Takai, Haruhiko Takeda, et al.. (2016). Sonazoid-enhanced ultrasonography guidance improves the quality of pathological diagnosis in the biopsy of focal hepatic lesions. European Journal of Gastroenterology & Hepatology. 28(12). 1462–1467. 19 indexed citations

15.

Eso, Yuji, Yoshitaka Nishikawa, & Atsushi Takai. (2016). Follicular lymphoma of the caecum resected endoscopically. Arab Journal of Gastroenterology. 17(3). 143–144. 1 indexed citations

16.

Sawai, Yugo, Yuzo Kodama, Takahiro Shimizu, et al.. (2015). Activation-Induced Cytidine Deaminase Contributes to Pancreatic Tumorigenesis by Inducing Tumor-Related Gene Mutations. Cancer Research. 75(16). 3292–3301. 23 indexed citations

17.

Eso, Yuji, Yukio Osaki, Tadashi Inuzuka, et al.. (2013). Bipolar percutaneous radiofrequency ablation of liver cancers: Report of an initial experience. Kanzo. 54(9). 577–588. 1 indexed citations

18.

Shimizu, Takahiro, Yuko Matsumoto, Yosuke Fujii, et al.. (2013). Leptin Receptor Somatic Mutations Are Frequent in HCV-Infected Cirrhotic Liver and Associated With Hepatocellular Carcinoma. Gastroenterology. 146(1). 222–232.e35. 32 indexed citations

19.

Eso, Yuji, Hiroyuki Marusawa, & Yukio Osaki. (2012). Hepatobiliary and Pancreatic: Detection of early hepatocellular carcinoma by enhanced magnetic resonance imaging. Journal of Gastroenterology and Hepatology. 27(2). 416–416. 5 indexed citations

20.

Kim, Soo Ki, Hiroyuki Marusawa, Yuji Eso, et al.. (2011). Clinical Characteristics of Non-B Non-C Hepatocellular Carcinoma: A Single-Center Retrospective Study. Digestion. 84(Suppl. 1). 43–49. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact